Unknown

Dataset Information

The search for drug-targetable diagnostic, prognostic and predictive biomarkers in chronic graft-versus-host disease.


ABSTRACT: INTRODUCTION:Chronic graft-versus-host disease (cGVHD) continues to be the leading cause of late morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT), which is an increasingly applied curative method for both benign and malignant hematologic disorders. Biomarker identification is crucial for the development of noninvasive and cost-effective cGVHD diagnostic, prognostic, and predictive test for use in clinic. Furthermore, biomarkers may help to gain a better insight on ongoing pathophysiological processes. The recent widespread application of omics technologies including genomics, transcriptomics, proteomics and cytomics provided opportunities to discover novel biomarkers. Areas covered: This review focuses on biomarkers identified through omics that

SUBMITTER: Ren HG 

PROVIDER: S-EPMC6017989 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature